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Abstract
 
Cerebral malaria (CM) causes death in children and nonimmune adults. TNF-
 
 
 
 has been
thought to play a key role in the development of CM. In contrast, the role of the related cyto-
kine lymphotoxin 
 
 
 
 (LT
 
 
 
) in CM has been overlooked. Here we show that LT
 
 
 
, not TNF
 
 
 
,
 
is the principal mediator of murine CM. Mice deficient in TNF
 
 
 
 (B6.TNF
 
 
 
 
 
/
 
 
 
) were as suscep-
tible to CM caused by 
 
Plasmodium berghei
 
 (ANKA) as C57BL/6 mice, and died 6 to 8 d after in-
fection after developing neurological signs of CM, associated with perivascular brain hemorrhage.
Significantly, the development of CM in B6.TNF
 
 
 
 
 
/
 
 
 
 mice was not associated with increased
intracellular adhesion molecule (ICAM)-1 expression on cerebral vasculature and the intralumi-
nal accumulation of complement receptor 3 (CR3)-positive leukocytes was moderate. In con-
trast, mice deficient in LT
 
 
 
 (B6.LT
 
 
 
 
 
/
 
 
 
) were completely resistant to CM and died 11 to 14 d
after infection with severe anemia and hyperparasitemia. No difference in blood parasite burden
was found between C57BL/6, B6.TNF
 
 
 
 
 
/
 
 
 
, and B6.LT
 
 
 
 
 
/
 
 
 
 mice at the onset of CM symp-
toms in the two susceptible strains. In addition, studies in bone marrow (BM) chimeric mice
showed the persistence of cerebral LT
 
 
 
 mRNA after irradiation and engraftment of LT
 
 
 
-defi-
cient BM, indicating that LT
 
 
 
 originated from a radiation-resistant cell population.
Key words: parasitic disease • protozoan infection • 
 
Plasmodium berghei
 
 • immunopathology • 
infection
 
Introduction
 
Cerebral malaria (CM) is a major cause of death in African
children infected with 
 
Plasmodium falciparum
 
 (1). This seri-
ous neurological condition is characterized by the seques-
tration of parasitized erythrocytes in cerebral blood vessels
(1). Because high levels of circulating TNF
 
  
 
are found in
the serum of CM patients, this cytokine is thought to play
an important role in CM (2, 3). This has been supported by
reports of TNF
 
 
 
 production in the brain during murine
CM caused by 
 
Plasmodium berghei
 
 ANKA (4, 5). In this ex-
perimental model of CM, anti-TNF
 
 
 
 antibodies (6) or sol-
uble TNF receptor (TNFR; reference 7) have also been
shown to attenuate the severity of symptoms and prevent
subsequent death. In addition, mice deficient in TNFR2
(p75) are resistant to CM (8).
In both human and murine CM, the blockage of cere-
bral vessels by parasitized RBCs (pRBCs) is thought to be
caused by TNF
 
 
 
-mediated up-regulation of adhesion mol-
ecules, such as intercellular adhesion molecule (ICAM)-1,
on the endothelium (1, 6). In mice, this is also associated
with the accumulation of activated leukocytes in the lumen
of brain micro-vessels (6). TNF
 
 
 
 is thought to mediate pa-
thology by either direct cytolytic effects or induction of an
inflammatory cascade involving mediators such as IFN-
 
 
 
and nitric oxide (NO; reference 9). However, the critical
role of TNF
 
 
 
 in human CM has recently been questioned
by the failure of TNF
 
 
 
-neutralizing reagents to decrease
the incidence of clinical CM (10, 11).
Recently, lymphotoxin 
 
 
 
 (LT
 
 
 
), a related member of
the TNF family, has been reported to have important, yet
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distinct, roles in various infectious and autoimmune disease
models (12, 13). LT
 
 
 
 forms a soluble homotrimer that
along with TNF
 
 
 
 is capable of binding both the TNFR1
and TNFR2. In addition, LT
 
 
 
 can form a cell-bound het-
erotrimer with two LT
 
 
 
 molecules, which binds the LT
 
 
 
receptor (14). Given the shared receptor usage of TNF
 
 
 
and LT
 
 
 
 (14), and the potential cross-reactivity of anti-
TNF
 
 
 
 antibodies with LT
 
 
 
 (15), it is possible that LT
 
 
 
,
and not TNF
 
 
 
, is the principal mediator of CM. To test
this hypothesis, C57BL/6 mice deficient in TNF
 
 
 
 or LT
 
 
 
were infected with 
 
P. berghei
 
 ANKA pRBCs and their sus-
ceptibility to CM was compared. Our results clearly show
that LT
 
 
 
, and not TNF
 
 
 
, is indeed the principal mediator
of murine CM.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice were purchased from Tuck and Co.
and were housed under conventional conditions. Mice deficient
in TNF
 
 
 
 (B6.TNF
 
 
 
 
 
/
 
 
 
) and both TNF
 
  
 
and LT
 
  
 
(B6.TNF
 
 
 
/
LT
 
 
 
 
 
/
 
 
 
; reference 16) were obtained from Bantin & Kingman,
while those deficient in LT
 
 
 
 
 
/
 
 
 
 (B6.LT
 
 
 
 
 
/
 
 
 
; reference 17) were
obtained from The Jackson Laboratory. In some experiments,
B6.LT
 
 
 
 
 
/
 
 
 
 mice generated from C57BL/6 mice embryonic stem
cells (12) were purchased from Bantin & Kingman and used to
confirm the resistance of LT
 
 
 
-deficient mice (17) to CM.
B6.Ly5.1 mice were obtained from Charles River Laboratories
(IFFA Credo). All mouse strains were bred at the London School
of Hygiene and Tropical Medicine under barrier conditions.
Mice used in all experiments were sex-matched and used at 6 wk
of age. Chimeric mice were prepared by irradiating animals twice
(48 h apart) with 5.5 Gy and then engrafting with 10
 
7
 
 fresh bone
marrow (BM) cells intravenously via the lateral tail vein within
2 h of the second radiation exposure. Mice were maintained on
antibiotics for 4 wk after engraftment and infected with parasites
8 wk after receiving BM.
 
Parasites, Infection, and Disease Assessment. P. berghei
 
 (ANKA)
was obtained from Dr. N. Wedderburn (Royal College of Sur-
geons, London, UK) and used in all experiments after one in
vivo passage in C57BL/6 mice. Mice were infected by injecting
10
 
4
 
 pRBCs intravenous via the lateral tail vein, as described pre-
viously (18). Animals were monitored for neurological signs of
CM, including convulsions, ataxia and paralysis. Parasite burden
was determined from Giemsa stained blood smears, as described
previously (18), and expressed as the percentage of pRBCs.
Blood hemoglobin levels were determined when collecting
blood using a Hemoglobin meter, according to the manufac-
turer’s instructions (Buffalo Medical Specialities). RBCs were
counted using a hemocytometer by diluting 2 
 
 
 
l of tail blood in
1 ml RPMI. Animals were monitored and killed by cervical dis-
location when death was deemed inevitable, according to UK
Home Office guidelines. Blood was harvested by cardiac punc-
ture for serum isolation. Brain tissue was carefully removed and
half was snap frozen on cork blocks in OCT embedding media
solution (Raymond A. Lamb, Eastbourne, UK) and stored at
–80
 
 
 
C until required for immunohistochemistry. The other half
was stored in RNAlater (Ambion) for 24 h at 4
 
 
 
C, before freez-
ing at –80
 
 
 
C until required for RNA extraction. Some tissue was
fixed in formol saline (4% vol/vol; formaldehyde) for wax em-
bedding and preparing tissue sections for hematoxylin and eosin
staining.
 
Real-time Reverse Transcription PCR.
 
RNA was isolated from
brain tissue using Tri Reagent (Sigma-Aldrich), and an RNeasy
Mini Kit with on-column DNase digestion (QIAGEN), accord-
ing to the manufacturers’ instructions. RNA was reverse tran-
scribed into cDNA as described previously (19, 20). Oligonucle-
otides (5
 
 
 
–3
 
 
 
) used for the specific amplification of LT
 
 
 
 were
AGGGGCCCAGGGACTCTCT (sense) and ACGATCCGT-
GCTTGCTCTC (antisense), and for amplification of the house
keeping gene hypoxanthine-guanine phosphoribosyl transfer-
ase (HPRT) were GTTGGATACAGGCCAGACTTTGTTG
(sense) and GATTCAACCTTGCGCTCATCTTAGGC (anti-
sense). The number of LT
 
 
 
 and HPRT cDNA molecules in each
sample was calculated by real-time reverse transcription (RT)-
PCR using QuantiTect SYBR green master mix (QIAGEN) and
a LightCycler (Roche), according to the manufacturers’ instruc-
tions. Standard curves were constructed with known amounts of
LT
 
 
 
 and HPRT cDNA, and the number of LT
 
 
 
 molecules per
1,000 HPRT molecules in each sample was calculated.
 
Measurement of Serum IFN-
 
 
 
 and Nitrate Levels.
 
Serum sam-
ples were diluted 1:2 and IFN-
 
 
 
 levels measured by ELISA, as
described previously (21). Serum nitrate levels were measured by
reducing nitrate to nitrite and using Griess reagent, as described
previously (22).
 
Immunohistochemistry on Cryostat Sections of the Brain
 
Antibod-
ies used for histology included mouse anti-
 
P. berghei
 
 polyclonal
antibody (18), anti-complement receptor 3 (CR3) (5C6; refer-
ence 23), and anti-CD54 (ICAM-1; KAT-1; Serotec). Brain tis-
sue responses were analyzed on 6 
 
 
 
m acetone-fixed cryostat tis-
sue sections stained with the above primary antibodies and
appropriate fluorescein-isothiocyanate (FITC)-conjugated sec-
ondary detection reagents according to the manufacturer’s in-
structions (Vector Laboratories). Sections were mounted in
Vectashield mounting media for fluorescence (Vector Laborato-
ries), before analysis on an Axioplan fluorescent microscope
(ZEISS). Images were recorded digitally using a MagnaFire Sp
digital camera (Optronics). In some experiments, peroxidase-
conjugated secondary reagents (Vector Laboratories) were used to
detect ICAM-1 and CR3 expression in brain tissue. These sec-
tions were then used to count ICAM-1–positive vessels and
CR3-positive cells in 25 consecutive microscope fields of view
using a 
 
 
 
40 objective (final magnification 
 
 
 
400).
 
Statistics.
 
Statistical analysis was performed for IFN-
 
 
 
 and ni-
trate levels using Student’s 
 
t
 
 test and for survival curves using
Kaplan-Meier plots and Log Rank tests.
 
Results and Discussion
 
LT
 
 
 
-deficient Mice Do Not Die from CM.
 
To determine
if LT
 
 
 
 is involved in CM, we first tested for LT
 
 
 
 produc-
tion using LT
 
 
 
-specific primers in a real-time RT-PCR
with mRNA isolated from the brains of C57BL/6 mice in-
fected with 
 
P. berghei
 
 and showing signs of CM (Fig. 1 a).
LT
 
  mRNA was constitutively expressed in the mouse
brain, and levels increased in mice with CM. Therefore,
we sought to investigate further if this cytokine played a
role in murine CM.
To distinguish the roles of TNF  and LT  in CM, we
infected mice deficient in these cytokines (B6.TNF  / 
and B6.LT  /  mice, respectively) with P. berghei (ANKA)
and monitored animals for signs of CM. Strikingly,
B6.TNF  /  mice began to show neurological symptoms1373 Engwerda et al. Brief Definitive Report
of CM, including ataxia, convulsions, and palsy, at the
same time as infected C57BL/6 mice (days 6–8 after infec-
tion). Within 12–24 h of the onset of neurological symp-
toms, all C57BL/6 and B6.TNF  /  mice had to be killed
(Fig. 1 b). In stark contrast, B6.LT  /  mice and those de-
ficient in both TNF  and LT  (B6.TNF/LT  /  mice)
failed to show any neurological symptoms associated with
CM. However, hemoglobin levels in B6.LT  /  mice
dropped from 14.5 –16 g/dL (at day 0 p.i.) to less than 4–6
g/dL (day 12 after infection), and RBC numbers decreased
from  1010/ml to 1–3   109/ml. These mice died be-
tween days 11–15 after infection. Such decreases in hemo-
globin and RBC numbers have previously been associated
with death by complications arising from anemia (9). Im-
portantly, when C57BL/6 and B6.TNF  /  mice died,
parasitemia ranged from 12–24% pRBCs and was similar
for all mouse strains (Fig. 1 c). B6.TNF/LT  /  mice have
previously been shown to be resistant to CM, but this resis-
tance was attributed to the absence of TNF  (24). These
results clearly show that LT , and not TNF , is the pri-
mary mediator of murine CM, and that the development
of CM is independent of blood parasitemia.
Both nitric oxide (NO) and IFN-  have been reported
to play important roles in the development of murine CM
(9, 24). Serum nitrate (an indirect measure of NO) and
IFN-  levels were reduced in mice deficient in either
TNF  or LT , compared with C57BL/6 mice at the onset
of CM symptoms in susceptible strains (Fig. 1, d and e, day
7 after infection). Subsequently, both IFN-  and nitrate
levels in the serum of B6.LT  /  and B6.TNF/LT  / 
mice rose such that by day 12 after infection they were
similar to the levels found in C57BL/6 mice. These data
are in agreement with previous studies that show reduced
NO and IFN-  levels in P. berghei-infected B6.TNF/
LT  /  mice (24). These results suggest that both TNF 
and LT  play a role in the production of NO and IFN- 
after infection with P. berghei. However, the development
of CM in B6.TNF  /  mice demonstrates that elevated
serum NO and IFN-  levels do not correlate with the de-
velopment of CM.
Changes to the Cerebral Vasculature of TNF- – and LT -
deficient Mice after P. berghei Infection. Histological exami-
nation of brain sections revealed the presence of RBCs
laden with malaria pigment (hemozoin) in C57BL/6 and
B6.TNF  /  mice at the time of death (Fig. 2, a–d). Small
vascular hemorrhages were also observed in these animals
(Fig. 2, a–d), but not in animals deficient in LT  at the
same time (Fig. 2, e and f). To determine if these anatomi-
cal features were associated with the presence of pRBCs in
the brain, sections were stained with anti-P. berghei anti-
body (Fig. 3 a). Significant numbers of pRBCs were found
in the cerebral blood vessels of C57BL/6 and B6.TNF  / 
Figure 1. In the absence of LT  the early death of
P. berghei ANKA-parasitized C57BL/6 mice is pre-
vented. (a) LT  mRNA is up-regulated in brains of
C57BL/6 mice with CM, as indicated by real-time
RT-PCR (n   3 mice per group). (b) Survival curves
of C57BL/6 (solid line), B6.TNF  /  (overlapping
C57BL/6 mice and indicated by arrow), B6.LT  / 
(dashed line), and B6.TNF/LT  /  (dotted line) mice
infected with P. berghei (ANKA). Results represent
pooled data from three independent groups of mice
(n   5 to 11 per group) in experiments conducted on
three separate occasions (total of n   16–22 mice per
group). Differences in survival between C57BL/6 or
B6.TNF  /  mice and mice deficient in LT  were
statistically different ( 2   39.39, P   0.0001). (c) Para-
sitemia over the course of P. berghei infection in
C57BL/6 (filled circle), B6.TNF  /  (open circle),
B6.LT  /  (filled triangle), and B6.TNF/LT  / 
(open triangle) mice. Arrow indicates the time point
(day 7) that CM developed in C57BL/6 and B6.TNF  /  mice. Data shown are from one experiment that is representative of the four performed. (d)
Serum nitrate and (e) serum IFN-  levels at day 7 and 12 postinfection (p.i.), as indicated. Statistically significant differences of P   0.05 are indicated (*).
Data shown are from one experiment that is representative of the three performed.1374 Lymphotoxin   Mediates Murine Cerebral Malaria
mice at the time of death (Fig. 3 a), but not in B6.LT  / 
and B6.TNF/LT  /  mice at the same time (day 7 after
infection; Fig. 3 a), despite blood parasitemias being the
same in all mouse strains at this time (Fig. 1 b). These data
suggest that pRBC were being retained in cerebral blood
vessels of mice that succumbed to CM.
Increased ICAM-1 expression is a feature of murine
CM and is thought to mediate binding of leukocytes and
possibly pRBCs to micro-vessels in the brain (25, 26).
ICAM-1 expression on vascular endothelial cells in the
brain was less in B6.TNF  /  mice than in C57BL/6
mice (Fig. 3 b; 438   22 ICAM-1  vessels per 25 fields of
view versus 894   16 ICAM-1  vessels per 25 fields of
view, respectively), but increased when compared with
expression in naive controls (Fig. 3 b; 245   9 ICAM-1 
vessels per 25 fields of view). Expression of ICAM-1 was
also reduced in B6.LT  /  and B6.TNF /LT  /  mice
at day 7 after (Fig. 3 b; 438   23 ICAM-1  vessels per 25
fields of view and 476   23 ICAM-1  vessels per 25 fields
of view, respectively). Associated with the decreased
ICAM-1 expression, in TNF  and LT -deficient mice,
there was also a decrease in the number of CR3-positive
inflammatory cells found in the brain (Fig. 3 c; 100   3,
427   23, 160   6, 165   5, and 151   7 CR3  cells per
25 fields of view for naive C57BL/6 mice, and C57BL/6,
B6.TNF  / , B6.LT  / , and B6.TNF /LT  /  mice
at day 7 after infection, respectively). Together, these re-
sults indicate that TNF  and LT  are both required for
optimal ICAM-1 up-regulation and leukocyte accumula-
tion in the brain during murine CM. However, these data
also show that these events do not necessarily predict the
development of CM.
LT  Is Produced by a Radiation-resistant Cell Population.
To assess whether leukocytes accumulating in the brain
were the source of LT  that mediated CM, BM chimeric
mice were constructed. Congenic B6.Ly5.1 mice were ir-
radiated and engrafted with BM from C57BL/6 mice or
animals lacking TNF , LT , or both (all express the Ly5.2
CD45 allele). After engraftment, chimeric mice contained
fewer than 2% Ly5.1-positive leukocytes in the spleen and
peripheral blood (data not shown). After infection with P.
berghei, chimeric mice engrafted with BM from C57BL/6
and B6.TNF  /  mice died at the same time as C57BL/6
and B6.TNF  /  mice (Fig. 4 a), and showed similar signs
of CM. The leukocytes that accumulated in the brain in
chimeric mice that developed CM were identified as being
of donor origin by staining brain tissue with anti-Ly5.2 an-
tibodies (data not shown). Surprisingly, chimeric mice en-
grafted with B6.LT  /  BM died in the ensuing 24 h of
CM (Fig. 4, a and c), in contrast to the prolonged survival
and lack of CM in B6.LT  /  mice. This observation in-
dicates that a radiation-resistant cell population in the brain
Figure 2. Perivascular hemorrhages are present in C57BL/6 and
B6.TNF  /  mice that develop CM. Sections (3  M) were prepared
from formol saline-fixed brain tissue and stained with hematoxylin and
eosin. Magnifications of  100 (a and b) and  400 (c and d) are shown
for C57BL/6 and B6.TNF  /  mice that died with CM. Areas within
the cerebellum (a, c, and e) and cerebrum (b, d, and f) are shown. Arrows
highlight sites of perivascular hemorrhage. These hemorrhages were not
observed in LT -deficient mice (e and f; original magnification:  100).
These data are representative of material obtained in four experiments (at
least 25 microscope fields from 12 or more samples from each mouse
strain were examined).
Figure 3. Comparative immunohis-
tochemical analysis of brain sections
taken from P. berghei-infected mice
when C57BL/6 and B6.TNF  / 
mice developed CM (day 7 after in-
fection). Brain cryosections (6  M)
were stained with (a) anti-P. berghei
antibodies, (b) anti-ICAM-1, and (c),
anti CR3 (5C6) mAbs with fluores-
cent secondary reagents. Original
magnification is  400. The samples
are representative of material from
four experiments.1375 Engwerda et al. Brief Definitive Report
is the major source of LT  during murine CM. However,
the fact that chimeric mice engrafted with BM from
B6.TNF/LT  /  mice survived a further 2–3 d (Fig. 4 a)
and died showing few signs of CM indicates that either
TNF  or LT  produced by leukocytes may contribute to
the pathology induced by a LT -producing, radiation-
resistant cell population. LT  mRNA was found in the
brains of all chimeric mice, including those engrafted with
BM from LT -deficient mice (Fig. 4 b), confirming that a
radiation-resistant cell population was the source of LT .
No LT  mRNA molecules were ever detected by real-
time RT-PCR in brain tissue from B6.LT  /  mice (data
not shown). Furthermore, when chimeric mice were pre-
pared by irradiating B6.TNF/LT  /  mice and engrafting
with BM from C57BL/6, B6.TNF  / , or B6.LT  / 
mice, all mice failed to develop CM (Fig. 4 c), and died
with anemia and hyperparasitemia (data not shown). The
extended survival of irradiated B6.TNF/LT  /  mice en-
grafted with BM from B6.TNF  /  mice indicates a role
for TNF  in the death of P. berghei-infected mice suffering
from anemia and hyperparasitemia. Although the LT -
producing cell population is likely to be of nonhematopoi-
etic origin, we cannot rule out the possibility that a long-
lived, radiation-resistant, BM-derived cell population is a
source of LT  in the brain. Similarly, we cannot yet rule
out any involvement of immune defects associated with
TNF - and LT -deficient mice in their different suscepti-
bility to CM. Nevertheless, these data show that LT  pro-
duced by a radiation-resistant cell is the key factor for the
development of murine CM.
In summary, we have shown that LT  produced by a ra-
diation-resistant cell population is the principal mediator of
murine CM. Both endothelial cells that line the brain vas-
culature, microglial cells or astrocytes in the brain paren-
chyma are potential sources of LT , as all are radiation-
resistant (27, 28) and capable of producing inflammatory
mediators (27, 29). Given the constitutive expression of
LT  mRNA in the brain, it is likely that LT  acts in syn-
ergy with a parasite product or a parasite-induced host me-
diator. In fact, mice that die with CM accumulate pRBC
in cerebral vessels (Fig. 3 a), despite having similar blood
parasitemia to LT -deficient mice (Fig. 1 c), potentially
providing increased levels of these products in the brain.
The identity of these factors is unknown, but a candidate
parasite product for this role is glycosylphosphatidylinositol
(GPI), the membrane anchor for various parasite surface
antigens that has been shown to increase expression of in-
flammatory mediators by macrophages and vascular endo-
tlial cells (30). The involvement of LT  in human CM is
unknown, but results from this work indicate that it should
be investigated.
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Figure 4. LT  is produced by a radiation-resistant cell population in the
brain. (a) Survival curves of chimeric B6.Ly5.1 mice engrafted with BM
from C57BL/6 (solid line), B6.TNF  /  (overlapping C57BL/6 mice and
indicated by arrow), B6.LT  /  (dashed line), and B6.TNF/LT  / 
(dotted line) mice infected with P. berghei. Results represent pooled data
from three independent groups of mice (n   4–6 per group) in experi-
ments conducted on three separate occasions (total of n   12–16 mice per
group). Differences in survival between B6.Ly5.1 mice engrafted with BM
from C57BL/6 or B6.TNF  /  mice and mice deficient in LT  were sta-
tistically different ( 2   7.01, P   0.01), as was the difference between
mice engrafted with BM from B6.LT  /  and B6.TNF/LT  /  mice
( 2   23.83, P   0.0001). (b) LT  mRNA is detected by real-time RT-
PCR in the brain of all chimeric B6.Ly5.1 mice following P. berghei infec-
tion (brain tissue collected at time of death). The source of engrafted BM
is indicated. (c) Survival curve of chimeric B6.Ly5.1 mice engrafted with
BM from C57BL/6, B6.TNF  /  or B6.LT  /  mice (all groups over-
lap; solid line), and chimeric B6.TNF/LT  /  mice engrafted with BM
from C57BL/6 (dotted line), B6.TNF  /  (dashed line), or B6.LT  / 
(dashed and dotted line) mice (n   4 per group). Differences in survival
between B6.Ly5.1 mice engrafted with BM from C57BL/6 and B6.TNF/
LT  /  mice engrafted with BM from C57BL/6, B6.TNF  / , or
B6.LT  /  mice were statistically different ( 2   15, P   0.0001), as was
the increased survival time of B6.TNF/LT  /  mice engrafted with BM
from B6.TNF  /  mice over all other groups ( 2   6.628, P   0.01).1376 Lymphotoxin   Mediates Murine Cerebral Malaria
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